Clinicopathologic variables
Feature . | n . | (%) . |
---|---|---|
Histology | ||
ADC | 90 | (68) |
SQCC | 25 | (19) |
LCUC | 18 | (13) |
Tumor differentiation | ||
Well differentiated (low grade) | 24 | (18) |
Moderately differentiated (intermediate grade) | 46 | (35) |
Poorly differentiated (high grade) | 63 | (47) |
Size | ||
mean (standard deviation) | 3.91 | (1.84) cm |
Tumor stage | ||
T1 | 30 | (23) |
T2 | 98 | (74) |
T3 | 4 | (3) |
Node stage | ||
N0 | 78 | (59) |
N1 | 44 | (33) |
N2 | 8 | (6) |
N3 | 2 | (2) |
p27 | ||
High (positive staining in >50% of nuclei) | 19 | (14) |
Low (positive staining in <50% of nuclei) | 114 | (86) |
K-ras | ||
Mutation | 30 | (23) |
No mutation | 102 | (77) |
Feature . | n . | (%) . |
---|---|---|
Histology | ||
ADC | 90 | (68) |
SQCC | 25 | (19) |
LCUC | 18 | (13) |
Tumor differentiation | ||
Well differentiated (low grade) | 24 | (18) |
Moderately differentiated (intermediate grade) | 46 | (35) |
Poorly differentiated (high grade) | 63 | (47) |
Size | ||
mean (standard deviation) | 3.91 | (1.84) cm |
Tumor stage | ||
T1 | 30 | (23) |
T2 | 98 | (74) |
T3 | 4 | (3) |
Node stage | ||
N0 | 78 | (59) |
N1 | 44 | (33) |
N2 | 8 | (6) |
N3 | 2 | (2) |
p27 | ||
High (positive staining in >50% of nuclei) | 19 | (14) |
Low (positive staining in <50% of nuclei) | 114 | (86) |
K-ras | ||
Mutation | 30 | (23) |
No mutation | 102 | (77) |